Should Bulls Quit Doing Drugs?

It may seem like biotech bulls are a bit too giddy here and should stop doing drugs, what with the rest of the tape mixed and slow.

However, the XBI (ETF for small/mid-cap bios) suggests a retest of prior $91.10 highs makes sense--Charts like to probe major prior levels. 

Beyond that, plenty of individual bios are setting up well behind names which have run, like EDIT.

More on this in my usual Midday Video for Members.